Merck Announces Third-Quarter 2020 Financial Results

Go back to Merck Announces Third-Quarter 2020 Financial Results

Merck (MRK) Tops Q3 EPS by 31c, Revenues Beat; Narrows & Raises FY20 Non-GAAP EPS Guidance Above Consensus, Provides FY20 Revs. Outlook

October 27, 2020 6:49 AM EDT

Merck (NYSE: MRK) reported Q3 EPS of $1.74, $0.31 better than the analyst estimate of $1.43. Revenue for the quarter came in at $12.6 billion versus the consensus estimate of $12.17 billion.

Third-Quarter 2020 Worldwide Sales Were $12.6 Billion, an Increase of 1%; Excluding the Impact from Foreign Exchange, Sales Grew 2%KEYTRUDA Sales Grew 21% to $3.7... More